FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 1952549 · Received January 7, 2011

Report

Report Number
2124215-2010-23275
Event Type
Injury
Date Received
January 7, 2011
Date of Event
December 4, 2010
Report Date
December 7, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT WILL BE UPDATED FOLLOWING RECEIPT OF ADDITIONAL INFORMATION.

Additional Manufacturer Narrative · 1

DURING SURGICAL INTERVENTION, THE PHYSICIAN TRIED WITHOUT AVAIL, TO REPOSITION THE RV LEAD. AS A RESULT, THE PRODUCT WAS EXPLANTED AND REPLACED WITH ANOTHER BOSTON SCIENTIFIC RV LEAD. THE EXPLANTED PRODUCT IS NOT INTENDED TO BE RETURNED FOR POST MARKET EVALUATIONS. IF NEW DETAILS ARE RECEIVED, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT FOUR DAYS POST IMPLANT THIS RIGHT VENTRICULAR LEAD EXHIBITED LOSS OF CAPTURE; LEAD DISLODGMENT SUSPECTED. WHILE NO ADVERSE PATIENT EFFECTS WERE REPORTED, SURGICAL INTERVENTION WAS SCHEDULED FOR LEAD REPOSITIONING AND AN INAPPROPRIATE SHOCK WAS REPORTED DUE TO ATRIAL FIBRILLATION.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention